| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.2B | $31.8B | $29.8B | $27.5B | $25.4B | $6.1B | $5.0B | $4.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | $1.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $6.1B | $5.3B | $5.0B | $3.8B | $4.3B | $3.3B | $2.7B | $2.2B |
| Net Income | $5.2B | $4.1B | $4.2B | $2.4B | $4.2B | $1.6B | $0.5B | $0.6B |
| EPS (Basic) | $5.46 | $4.03 | $3.85 | $2.10 | $3.55 | $1.34 | $0.43 | $0.50 |
| EPS (Diluted) | $5.41 | $3.99 | $3.84 | $2.09 | $3.52 | $1.32 | $0.43 | $0.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $80.2B | $81.6B | $82.2B | $78.7B | $75.8B | $70.4B | $51.3B | $43.3B |
| Current Assets | $59.8B | $61.1B | $62.6B | $57.5B | $52.6B | $51.0B | $38.5B | $33.0B |
| Cash & Equivalents | $8.0B | $6.6B | $9.1B | $7.8B | $5.2B | $4.8B | $7.3B | $7.6B |
| Total Liabilities | $59.9B | $61.2B | $61.1B | $58.4B | $54.1B | $50.3B | $34.4B | $27.9B |
| Current Liabilities | $46.4B | $48.4B | $48.5B | $45.1B | $43.0B | $38.4B | $26.9B | $25.9B |
| Stockholders' Equity | $20.3B | $20.4B | $21.1B | $20.3B | $21.7B | $20.0B | $16.9B | $15.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.4B | $7.5B | $4.8B | $5.8B | $6.3B | $5.9B | $4.6B | $5.5B |
| Investing Cash Flow | $0.8B | $1.6B | $0.8B | $-3.4B | $-5.5B | $-16.2B | $-5.7B | $0.8B |
| Capital Expenditures | $0.9B | $0.7B | $0.6B | $0.7B | $0.9B | $0.9B | $0.7B | $0.8B |
| Financing Cash Flow | $-6.0B | $-8.3B | $-3.0B | $-1.1B | $-0.8B | $12.5B | $3.7B | $-1.3B |